Optionale Produktanalyse
Mit Ihrer Erlaubnis verwenden wir datenschutzfreundliche Analysen, um zu verstehen, welche Recherchewege funktionieren. Wir verwenden weder Werbe-Tracker noch Sitzungsaufzeichnungen. Sie können diese Auswahl in den Einstellungen ändern. Lesen Sie die Datenschutzerklärung.
Texas Instruments Incorporated's published Sell conclusion compares the analysis-date price with fair value and potential value. Read the full report for assumptions, evidence, and material risks.
| Market cap | $236.5B | |
|---|---|---|
| Revenue (ttm) | 20.8B | |
| Net income (ttm) | 7.1B | |
| EPS (ttm) | $7.72 | |
| Shares out | 913.8M | |
| P/E (trailing) | 40.2x | |
| P/E (forward) | 26.1x | |
| Dividend | $6.08 (1.98%) | |
| Volume | 4,126,503 | |
| Beta | 1.34 |
Recent price action with selectable time range.
| Item | P1 | P2 | P3 | P4 | P5 | Trend |
|---|---|---|---|---|---|---|
| Period | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | Trend |
| Revenue | $18.34B | $20.03B | $17.52B | $15.64B | $17.68B | -0.9% |
| Gross profit | $12.38B | $13.77B | $11.02B | $9.09B | $10.08B | -5.0% |
| Operating income | $8.96B | $10.14B | $7.33B | $5.47B | $6.02B | -9.5% |
| Net income | $7.77B | $8.75B | $6.51B | $4.80B | $5.00B | -10.4% |
| EPS (diluted) | $8.26 | $9.41 | $7.07 | $5.20 | $5.45 | -9.9% |
| EBITDA | $10.06B | $11.23B | $8.50B | $7.54B | $8.25B | -4.8% |
| R&D | $1.55B | $1.67B | $1.86B | $1.96B | $2.08B | +7.6% |
| SG&A | $1.67B | $1.70B | $1.83B | $1.79B | $1.86B | +2.8% |
Recent company headlines from major financial publishers.
The path is supported if FY2027 revenue and diluted EPS remain within their dated forecast ranges. Results below those ranges would weaken the expected recovery.
This path raises profit and cash without requiring investors to pay a higher valuation for each dollar of earnings. Persistent heavy reinvestment would disconfirm it.
| Ke ↓ / g → | 1.5% | 2.0% | 2.5% | 3.0% | 3.5% |
|---|---|---|---|---|---|
| 7.9% | $126 | $130 | $135 | $140 | $148 |
| 8.9% | $114 | $117 | $120 | $124 | $129 |
| 9.9% | $105 | $107 | $110 | $112 | $115 |
| 10.9% | $97.8 | $99.4 | $101 | $103 | $105 |
| 11.9% | $91.7 | $92.9 | $94.3 | $95.8 | $97.4 |
Upcoming earnings date and setup when available.
Das Rating, das die veröffentlichte Research-Ausgabe des jeweiligen Monats trug. Ein Rating vergleicht den Kurs zum Analysezeitpunkt mit dem Fair Value; es ist kein Nachweis, ob die Einschätzung zutraf.
| Jahr | Jan | Feb | Mär | Apr | Mai | Jun | Jul | Aug | Sep | Okt | Nov | Dez |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 |
